Company news: WebMD, Wolters Kluwer

Share this article:
John Kritzmacher, former EVP and CFO of Global Crossing, has jumped over to WebMD to be its SVP of business operations, organizational planning and structure. Human Resources, Corporate Communications and Strategy will report directly to Kritzmacher, who in turn reports to WebMD CEO Cavan Redmond. Before WebMD and Global Crossing, Kritzmacher was the chief operating officer for Alcatel-Lucent. Monday's announcement is one of several recent changes at the health portal, which has been fighting for advertisers. Changes include the June hiring of CEO Redmond and last month's magazine revamp.

Healthcare information company Wolters Kluwer has named Cathy Wolfe president and CEO of the medical research division. Wolfe, who joined Wolters Kluwer in 1996, most recently served as CEO of Wolters Kluwer UK. She will replace Karen Abramson, who has headed up medical research for the past six years. Abramson was named president and CEO of the company's tax and accounting business unit, CCH, in September.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.